Advertisement

Highlights of Abstracts on Hematopoietic Stem Cell Transplant in Annual Conference of ISHBT 2018

  • Preethi Jeyaraman
  • Rahul Naithani
Review Article
  • 4 Downloads

Abstract

Stem cell transplant in India has been seeing a steady progressive growth over the last decade. Thirty abstracts related to various aspects of bone marrow transplant were presented in the annual conference of Indian Society of Hematology and Transfusion medicine in 2018. All abstracts which were published were reviewed. They were categorized into autologous transplants, allogeneic transplants, lab aspects and supportive care. They have been summarized to provide a snapshot of the data presented. These data are likely to encourage to start or enhance transplant activity at other centers.

Keywords

HSCT India Late effects DLI 

Notes

Compliance with Ethical Standards

Conflict of interest

The author declares that they have no conflict of interest.

References

  1. 1.
    Naithani R (2018) Hematopoietic stem cell transplantation in India-2017 annual update. Indian J Hematol Blood Transfus 34(1):5–7CrossRefGoogle Scholar
  2. 2.
    Modak K, Radhakrishnan V, Lama M, Kathrotiya M, Bhave JS, Kumar J et al (2018) Outcomes of consolidation with R-BEAM high dose chemoimmunotherapy and autologous hematopoietic cell rescue in high risk B-cell lymphoma: a tertiary care single center experience. Indian J Hematol Blood Transfus. November, S 385Google Scholar
  3. 3.
    Pai AA, Mani S, Panetta CJ, Ezhilpavai M, Stallon I, Balkrishnan B et al (2018) Pharmacokinetics of melphalan in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation. Indian J Hematol Blood Transfus. November, S 380Google Scholar
  4. 4.
    Kulkarni U, Devasia AJ, Korula A et al (2018) Clinical outcomes in multiple myeloma post-autologous transplantation—a single centre experience. Indian J Hematol Blood Transfus.  https://doi.org/10.1007/s12288-018-0989-y Google Scholar
  5. 5.
    Malhotra P, Yanamandra U, Khadwal A et al (2018) Autologous stem cell transplantation for multiple myeloma: single centre experience from North India. Indian J Hematol Blood Transfus 34(2):261–267CrossRefGoogle Scholar
  6. 6.
    Naithani R, Dayal N, Rai R, Pathak S, Singh M (2018) Autologous hematopoietic stem cell transplantation for multiple myeloma in India. Indian J Hematol Blood Transfus 34(3):564–565CrossRefGoogle Scholar
  7. 7.
    Kapoor J, Soni P, Bhatia N, Agrawal N, Ahmed R, Mehta P et al (2018) Clinical profile and outcomes post allogenic hematopoietic stem cell transplantation in thalassemia patients: A single centre experience. Indian J Hematol Blood Transfus 50–51Google Scholar
  8. 8.
    Korula A, Devasia AJ, Fouzia NA et al (2018) Outcomes following allogeneic stem cell transplantation using non-sibling family donors. Indian J Hematol Blood Transfus.  https://doi.org/10.1007/s12288-018-0988-z Google Scholar
  9. 9.
    Nikila R, Patel S, Sankaran M, Venkateswaran VS, Kesavan MR, Ramya U et al (2018) Balancing cure versus toxicity-haematopoietic stem cell transplantation for sickle cell anemia. Indian J Hematol Blood Transfus. November, S 200Google Scholar
  10. 10.
    Venkateswaran VS, Patel S, Sankaran M, Kesavan MR, Nikila R, Ramya U et al (2018) Treosulfan based conditioning regimen—reduced toxicity with excellent outcomes in children with primary immune deficiency. Indian J Hematol Blood Transfus. November, S 53Google Scholar
  11. 11.
    Uppuluri R, Sivasankaran M, Patel S, Swaminathan VV, Ravichandran N, Ramanan KM et al (2018) Haematopoietic stem cell transplantation for children with inherited bone marrow failure syndromes: a single centre experience over 15 years from India. Indian J Hematol Blood Transfus. November, S 204Google Scholar
  12. 12.
    Lahane CG, Apte S, Subramanian K, Phatale R, Roshan R (2018) Outcome of allogenic stem cell transplant in acute myeloid leukemia patients in a single centre over 7 yrs. Indian J Hematol Blood Transfus. November, S 378Google Scholar
  13. 13.
    Selvarajan S, Korula A, Fouzia NA, Abraham A, Srivastava A, Mathews V et al (2018) Outcomes of allogeneic hematopoietic stem cell transplantation for lymphomas: a single-centre experience. Indian J Hematol Blood Transfus. November, S 54Google Scholar
  14. 14.
    Venkateswaran VS, Meena S, Shivani P, Keasvan MR, Nikila, Ramya U et al (2018) Donor lymphocyte infusion in children—efficacy in preventing graft rejection and relapse— experience from a tertiary referral centre in southern India. Indian J Hematol Blood Transfus. November, S 10Google Scholar
  15. 15.
    Reba H, Korula A, Abraham A, Sindhuvi E, Lakshmi K, George B et al (2018) Impact of donor lymphocyte infusion in malignant and nonmalignant disease post-allogeneic stem cell transplant. Indian J Hematol Blood Transfus. November, S 383Google Scholar
  16. 16.
    Nagarajan R, Pai AA, Ravichandran AJ, Mani S, Mohanan E, Balakrishnan B et al (2018) GSTA1*B genotype influences intravenous busulfan pharmacokinetics and targeted dose adjustment in patients undergoing HSCT with busulfan based conditioning regimen. Indian J Hematol Blood Transfus. November, S 379Google Scholar
  17. 17.
    Balasubramanian P, Pai A, Ezhilpavai M, Nagarajan R, Eunice SE, Kavitha ML et al (2018) Targeted iv busulfan-based conditioning regimen in patients with acute myelogenous leukemia undergoing allogeneic hematopoietic stem cell transplantation—a single centre experience. Indian J Hematol Blood Transfus 34–35Google Scholar
  18. 18.
    Bharath Ram S, Bhat S, Nataraj KS, Badiger S, Kailasnath VP, Mallya P et al (2018) A prospective observational study of incidence of early cytomegalovirus reactivation and factors affecting it following allogeneic stem cell transplantation. Indian J Hematol Blood Transfus 205–206Google Scholar
  19. 19.
    Devasia AJ, Mammen S, Korula A, Abraham A, Fouzia NA et al (2018) A low incidence of cytomegalo virus infection following allogeneic hematopoietic stem cell transplantation despite a high seroprevalence. Indian J Hematol Blood Transfus 34(4):636–642CrossRefGoogle Scholar
  20. 20.
    Suraj C, Korula A, Fouzia NA, Kavitha ML, Abraham A, Srivastava A, Mathews V et al (2018) Antifungal prophylaxis in acute GVHD post stem cell transplant—a single centre experience from Southern India. Indian J Hematol Blood Transfus. November, S 206Google Scholar
  21. 21.
    Upreti R, Sharma S, Satyanand K, Kapoor A, Asthana B, Venkatesan S et al (2018) Initial HSCT in non-HEPA filter AHU rooms: a single center experience. Indian J Hematol Blood Transfus. November, S 196Google Scholar
  22. 22.
    Kumar R, Kapoor R, Asthana B et al (2017) Single dose preemptive plerixafor for stem cell mobilization for ASCT after lenalidomide based therapy in multiple myeloma: impact in resource limited setting. Indian J Hematol Blood Transfus 33(4):463–469CrossRefGoogle Scholar
  23. 23.
    Kumar K, Chezhian S, Prabhu D, Asokan L, Dharani B et al (2018) On demand plerixafor as a rescue strategy in healthy donors to achieve adequate stem cells—a pilot study. Indian J Hematol Blood Transfus. November, S 201Google Scholar
  24. 24.
    Prabha L, Kumar K, Chezhian S (2018) Psychiatric illness in bone marrow transplantation patients. Indian J Hematol Blood Transfus. November, S 203Google Scholar
  25. 25.
    Sathianathan P, George B (2018) Quality of life among allogenic hematopoietic stem cell transplant patients. Indian J Hematol Blood Transfus. November, S 386Google Scholar
  26. 26.
    Kesavan MR, Patel S, Sivasankaran M, Venkateswaran VS, Nikila R, Uppuluri R et al (2018) Normal growth and development post haematopoietic stem cell transplantation for thalassemia major using treosulfan based conditioning regimen—single centre long term study. Indian J Hematol Blood Transfus. November, S 49Google Scholar
  27. 27.
    Naithani R, Dayal N, Dixit G (2017) Single versus dual platform analysis for hematopoietic stem cell enumeration using ISHAGE protocol. Indian J Hematol Blood Transfus 33(3):370–374CrossRefGoogle Scholar
  28. 28.
    Mishra S, Mammen JJ, George B, Nair S, Kulkarni U, Matthews N et al (2018) A study to compare Haematopoietic Progenitor Cell (HPC) determined on the Sysmex XN-9000 with flowcytometric CD34 count in peripheral blood and in the harvested peripheral blood stem cell graft from autologous and allogenic donors. Indian J Hematol Blood Transfus. November, S 9Google Scholar
  29. 29.
    Vani S, Devi AS, Chandramouleeswaran N, Meganathan V, Kumar NM, Yogesh NK et al (2018) Next generation sequencing: an accurate and unambiguous method for HLA whole genome typing. Indian J Hematol Blood Transfus. November, S 195Google Scholar
  30. 30.
    Srinivasan G, Eswari S, Sumithra S, Shaji RV, Edison ES (2018) Comparison of DNA based chimerism analysis with direct amplification using whole blood. Indian J Hematol Blood Transfus. November, S 202Google Scholar

Copyright information

© Indian Society of Hematology and Blood Transfusion 2019

Authors and Affiliations

  1. 1.Division of Hematology and Bone Marrow TransplantationMax Super Speciality Hospital, SaketNew DelhiIndia

Personalised recommendations